Targeting lipid metabolism to reduce pro-inflammatory phenotype and viability of senescent cells

Cells, when damaged, often do not die, but become senescent (“zombie”) and start producing nefarious substances. This way, senescent cells damage surrounding healthy cells, cause tissue inflammation and contribute to age-related diseases. Recent evidence has shown that the elimination of these senescent cells can slow down the onset of a range of age-related diseases such as Alzheimer’s disease, atherosclerosis and diabetes. Dr. Ogrodnik’s research is aimed at understanding senescent cells and finding out how to disable their aggressive behavior towards healthy cells.

More 2019 Recipients of this Grant

Laura Bott, PhD

Elucidating intra- and inter-individual variability in proteostasis network capacity during aging

Laura Bott
Nirmalya Dasgupta, PhD

A role for histone chaperone HIRA in cytoplasmic DNA sensing and senescence-associated inflammatory signaling

Nirmalya Dasgupta
Yoko Henderson, PhD

Determining the effects of late-life initiated caloric restriction on aging-related cognitive decline, frailty, and H2S production

Yoko Henderson
Ryo Higuchi-Sanabria, PhD

More than just a load control: cytoskeletal form and function during aging

Ryo Higuchi-Sanabria
Li Li, MD, PhD

A mitochondrial membrane-spanning ternary complex is a drug target for aging and Parkinson's disease

Li Li
Elise Marsan, PhD

Glial dysfunctions in brain aging and neurodegenerative diseases

Elise Marsan
Seungjin Ryu, PhD

The role of a matricellular adipokine in aging by integration of immune-metabolic response

Seungjin Ryu
Kevin Stein, PhD

Defining the role of co-transitional proteostasis in aging and age-related pathologies

Kevin Stein
Matthew Ulgherait, PhD

Engineering the microbiome to ameliorate age-related intestinal diseases and extend lifespan in Drosophila

Matthew Ulgherait